Olsson H - Search Results

1

Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes.

Loman N, Johannsson O, Bendahl PO, Borg A, Fernö M, Olsson H. Loman N, et al. Among authors: olsson h. Cancer. 1998 Jul 15;83(2):310-9. Cancer. 1998. PMID: 9669814

2

Early oral contraceptive use and premenopausal breast cancer--a review of studies performed in southern Sweden.

Olsson H, Borg A, Fernö M, Möller TR, Ranstam J. Olsson H, et al. Cancer Detect Prev. 1991;15(4):265-71. Cancer Detect Prev. 1991. PMID: 1794133

3

Her-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormones.

Olsson H, Borg A, Fernö M, Ranstam J, Sigurdsson H. Olsson H, et al. J Natl Cancer Inst. 1991 Oct 16;83(20):1483-7. doi: 10.1093/jnci/83.20.1483. J Natl Cancer Inst. 1991. PMID: 1920494

4

Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis.

Borg A, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Olsson H, Killander D, McGurie WL. Borg A, et al. Among authors: olsson h. Br J Cancer. 1991 Jan;63(1):136-42. doi: 10.1038/bjc.1991.28. Br J Cancer. 1991. PMID: 1989653 Free PMC article.

5

Proliferation and DNA ploidy in malignant breast tumors in relation to early oral contraceptive use and early abortions.

Olsson H, Ranstam J, Baldetorp B, Ewers SB, Fernö M, Killander D, Sigurdsson H. Olsson H, et al. Cancer. 1991 Mar 1;67(5):1285-90. doi: 10.1002/1097-0142(19910301)67:5<1285::aid-cncr2820670502>3.0.co;2-q. Cancer. 1991. PMID: 1991290

6

Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels.

Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Fernö M, Killander D, Olsson H, Ranstam J. Sigurdsson H, et al. Among authors: olsson h. Br J Cancer. 1990 Nov;62(5):786-90. doi: 10.1038/bjc.1990.380. Br J Cancer. 1990. PMID: 2245171 Free PMC article.

7

Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation.

Fernö M, Baldetorp B, Bendahl PO, Borg A, Ewers SB, Olsson H, Rydén S, Sigurdsson H, Killander D. Fernö M, et al. Among authors: olsson h. Breast Cancer Res Treat. 1995;36(1):23-34. doi: 10.1007/BF00690181. Breast Cancer Res Treat. 1995. PMID: 7579503 Clinical Trial.

8

Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group.

Fernö M, Baldetorp B, Borg A, Brouillet JP, Olsson H, Rochefort H, Sellberg G, Sigurdsson H, Killander D. Fernö M, et al. Among authors: olsson h. Eur J Cancer. 1994;30A(14):2042-8. doi: 10.1016/0959-8049(94)00307-q. Eur J Cancer. 1994. PMID: 7857700

9

ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer.

Borg A, Baldetorp B, Fernö M, Killander D, Olsson H, Rydén S, Sigurdsson H. Borg A, et al. Among authors: olsson h. Cancer Lett. 1994 Jun 30;81(2):137-44. doi: 10.1016/0304-3835(94)90194-5. Cancer Lett. 1994. PMID: 7912163 Clinical Trial.

10

High frequency of allelic imbalance at the BRCA1 region on chromosome 17q in both familial and sporadic ductal breast carcinomas.

Borg A, Zhang QX, Johannsson O, Olsson H. Borg A, et al. Among authors: olsson h. J Natl Cancer Inst. 1994 May 18;86(10):792-4. doi: 10.1093/jnci/86.10.792. J Natl Cancer Inst. 1994. PMID: 8169978 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

889 results

Search Page

Filters